DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kay J, Fleischmann R, Keystone E. et al.
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Ann Rheum Dis 2015;
74: 538-546
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.